Total | With coronary heart disease | Without coronary heart disease | ||
---|---|---|---|---|
Diabetes Medication | ||||
Thiazolidinedione | Crude | 1.77 (1.01 - 3.09) | 1.73 (0.47 - 1.58) | 1.71 (0.91 - 3.21) |
Adjusted a | 1.75 (0.99 - 3.08) | 1.58 (0.41 - 6.07) | 1.68 (0.89 - 3.17) | |
Adjusted b | 1.42 (0.79 - 2.57)1 | 0.94 (0.28 - 3.17)2 | 1.52 (0.81 - 2.85)3 | |
Oral combination drug | Crude | 2.48 (1.51 - 5.34) | 2.81 (0.33 - 23.79) | 2.45 (1.07 - 5.61) |
Adjusted a | 1.97 (0.94 - 4.13) | 1.82 (0.21 - 15.96) | 1.91 (0.82 - 4.45) | |
Adjusted b | 2.06 (0.98 - 4.31)4 | 1.93 (0.38 - 9.78)5 | 1.87 (0.84 - 4.13)6 | |
Coronary Heart Disease Medication | ||||
Angiotensin-converting enzyme inhibitor | Crude | 1.46 (1.14 – 1.86) | 2.17 (1.12 – 4.20) | |
Adjusted a | 1.52 (1.18 – 1.95) | 2.18 (1.09 – 4.35) | ||
Adjusted c | 1.44 (1.11 – 1.88)7 | - | ||
Adjusted d | - | 2.61 (1.26 – 5.42)8 | ||
Calcium channel blocker | Crude | 1.45 (1.10 – 1.91) | 2.94 (1.38 – 6.24) | |
Adjusted a | 1.55 (1.17 – 2.06) | 3.53 (1.58 – 7.89) | ||
Adjusted c | 1.42 (1.05 – 1.91)9 | - | ||
Adjusted d | 3.64 (1.55 – 8.52)10 | |||
Aspirin | Crude | 1.52 (1.17 – 1.96) | 1.10 (0.58 – 2.08) | |
Adjusted a | 1.80 (1.38 – 2.36) | 0.96 (0.49 – 1.87) | ||
Adjusted e | 1.36 (1.01 – 1.84)11 | - | ||
Adjusted f | - | 1.12 (0.57 – 2.21)12 |